I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 3.18 THB -3.64%
Market Cap: 1.9B THB
Have any thoughts about
Inter Pharma PCL?
Write Note

Inter Pharma PCL
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inter Pharma PCL
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
Inter Pharma PCL
SET:IP
Revenue
฿1.8B
CAGR 3-Years
59%
CAGR 5-Years
41%
CAGR 10-Years
N/A
D
Do Day Dream PCL
SET:DDD
Revenue
฿1.5B
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
N/A
T
Thai Nippon Rubber Industry PCL
SET:TNR
Revenue
฿2.1B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
K
Karmarts PCL
SET:KAMART
Revenue
฿3B
CAGR 3-Years
33%
CAGR 5-Years
15%
CAGR 10-Years
12%
A
Asian Phytoceuticals PCL
SET:APCO
Revenue
฿226.7m
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
D
DOD Biotech PCL
SET:DOD
Revenue
฿683m
CAGR 3-Years
-16%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Inter Pharma PCL
Glance View

Market Cap
1.9B THB
Industry
Consumer products

Inter Pharma PCL is engaged in biopharmaceutical business. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2019-11-05. The firm is principally engaged in the importing, manufacturing and distribution of dietary supplement product for humans and animals. The firm provides wellness and anti-aging products, aesthetic innovation products, animal health products and livestock products. Its wellness and anti-aging products include Probac7, Probac10 plus, TS6, Beta Glucan Plus, Pure Krill Oil, Astacurmin and YUUU Cleansing Mousse. Its aesthetic innovation products include Perfectha Complement, Perfectha Derm, Perfectha Deep and Perfectha Subskin. The Company’s animal health products include Dr.Choice Cal-B, Dr.Choice Cardi-B, Petinol, Pet Select Senior, Pet Select Osteoflex and Malaseb Shampoo for dogs and cats. The company also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., Modern Pharma Co., Ltd. and Inter Petrina Co., Ltd.

IP Intrinsic Value
7.83 THB
Undervaluation 59%
Intrinsic Value
Price
I

See Also

What is Inter Pharma PCL's Revenue?
Revenue
1.8B THB

Based on the financial report for Dec 31, 2023, Inter Pharma PCL's Revenue amounts to 1.8B THB.

What is Inter Pharma PCL's Revenue growth rate?
Revenue CAGR 5Y
41%

Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for Inter Pharma PCL have been 59% over the past three years , 41% over the past five years .

Back to Top